0001656472-23-000155.txt : 20231219
0001656472-23-000155.hdr.sgml : 20231219
20231219170429
ACCESSION NUMBER: 0001656472-23-000155
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231217
FILED AS OF DATE: 20231219
DATE AS OF CHANGE: 20231219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weigensberg Arye
CENTRAL INDEX KEY: 0001937121
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38403
FILM NUMBER: 231498283
MAIL ADDRESS:
STREET 1: 111 PETER STREET, SUITE 300
CITY: TORONTO
STATE: A6
ZIP: MV5 2H1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cronos Group Inc.
CENTRAL INDEX KEY: 0001656472
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
BUSINESS PHONE: (416) 504-0004
MAIL ADDRESS:
STREET 1: 111 PETER STREET
STREET 2: SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M5V 2H1
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaCan Capital Corp.
DATE OF NAME CHANGE: 20151021
4
1
wk-form4_1703023454.xml
FORM 4
X0508
4
2023-12-17
0
0001656472
Cronos Group Inc.
CRON
0001937121
Weigensberg Arye
111 PETER STREET, SUITE 300
TORONTO
A6
M5V 2H1
ONTARIO, CANADA
0
1
0
0
See Remarks
0
COMMON SHARES
2023-12-17
4
M
0
1532
0
A
27974
D
RESTRICTED STOCK UNITS
2023-12-17
4
M
0
1532
0
D
COMMON SHARES
1532
107554
D
Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
On December 17, 2020, the reporting person was granted 4,596 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
Senior Vice President, Head of Research and Development
/s/ Aaron B. Werner, as attorney-in-fact for Arye Weigensberg
2023-12-19